FIELD: medicine. SUBSTANCE: the suggested diagnostic kit to detect schizophrenia deals with measuring the serumal content of epidermal growth factor due to antibody against epidermal growth factor. The present diagnostic kit should be applied for carrying out diagnostics of schizophrenia, acute and chronic schizophrenia. The advantage of the present innovation deals with detection of new marker to be applied for diagnostics of schizophrenia. EFFECT: higher accuracy of diagnostics. 11 cl, 4 dwg
Authors
Dates
2003-11-20—Published
2001-10-30—Filed